文献速递其他结缔组织病

系统性硬化症皮肤受累患者报告结局量表的开发与验证

Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2017-02-17

本研究开发并验证了用于评估系统性硬化症(SSc)患者皮肤相关生活质量的量表SSPRO。140例SSc患者完成22条目量表,心理测量学分析支持四因子结构,信效度良好,与患者报告指标相关性高,与医生评估指标相关性较低。

要点

  • SSPRO为基于患者输入开发的22条目量表,经认知访谈和专家小组修订。
  • 探索性因子分析支持四个维度:躯体影响、躯体限制、情绪影响和社会影响。
  • 量表信效度良好,与患者报告指标强相关,与医生评估指标弱相关。

核心结论

  • SSPRO经过广泛患者输入开发,显示出信度和效度证据,可作为现有SSc皮肤受累评估的补充,侧重患者体验。

研究设计与样本

  • 通过焦点小组收集患者皮肤相关健康影响,开发条目并经认知访谈和专家小组修订,形成22条目SSPRO进行现场测试。
  • 心理测量学分析包括重测信度、内部一致性和探索性因子分析,并通过与其他患者和医生评估指标的相关性评估结构效度。

主要发现

  • 140例参与者完成SSPRO:平均年龄53.4岁,中位疾病病程5年,82.1%为女性,32.9%为弥漫性皮肤型SSc。
  • 探索性因子分析支持四个因子,对应假设结构:躯体影响、躯体限制、情绪影响和社会影响;删除22条目中的4条后拟合统计可接受。
  • 重测信度(组内相关系数=0.61-0.83)为中至高度,内部一致性(Cronbach's α=0.89-0.96)为高。
  • SSPRO与其他患者报告指标强相关(r=0.59-0.88),与医生评估指标相关性较低(r=0.31-0.40)。
  • SSPRO评分在患者报告皮肤严重程度的各水平间以及局限型与弥漫型皮肤SSc间存在显著差异。

临床怎么用

  • SSPRO可用于评估SSc患者皮肤相关生活质量,补充现有医生评估指标,强调患者体验。

局限性

  • 需要进一步研究评估SSPRO对变化的敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We developed a patient-reported outcome (PRO) instrument to assess the skin-related quality of life in patients with systemic sclerosis (SSc). METHODS: Participants with SSc provided input on skin-related health effects through focus groups. We developed items for scleroderma skin PRO (SSPRO) to encompass these effects. Further consideration from cognitive interviews and an expert panel led to reduction and modification of items. A 22-item SSPRO was field tested. Psychometric analysis included test-retest reliability, internal consistency and exploratory factor analysis (EFA). Construct validity was assessed through correlation with other participant and physician-assessed measures. RESULTS: 140 participants completed the SSPRO: mean age was 53.4 years, median disease duration was 5 years, 82.1% were female and 32.9% had diffuse cutaneous SSc. EFA supported four factors in SSPRO corresponding to hypothesised constructs: physical effects, physical limitations, emotional effects and social effects. Removal of 4/22 items resulted in acceptable goodness-of-fit statistics. Test-retest reliability (intraclass correlation coefficient=0.61-0.83) was moderate to high and internal consistency (Cronbach's α=0.89-0.96) was high. SSPRO correlated strongly with other participant-reported measures (r=0.59-0.88) suggesting construct validity, and less well with physician-assessed measures (r=0.31-0.40). SSPRO scores were significantly different for each level of participant-reported skin severity, and for limited versus diffuse cutaneous SSc. CONCLUSIONS: SSPRO has been developed with extensive patient input and demonstrates evidence for reliability and validity. It is complementary to existing measures of SSc skin involvement with emphasis on the patient's experience. Further research is needed to assess its sensitivity to change.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Man A, Correa JK, Ziemek J, et al. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Ann Rheum Dis. 2017. PMID: 28213563. doi:10.1136/annrheumdis-2016-210534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。